Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Philip Morris

Philip Morris must pay down debt after buying Swedish Match. The dividend isn't going anywhere, but keep expectations modest.

What Can Investors Expect From This Stock and its 5% Yield?

Albemarle

Cincinnati Financial

Canadian National Railway Company

Carlisle Companies

Dover

W.W. Grainger

Leggett & Platt

Lowe's

National Fuel Gas

Sysco

12 Dividend Aristocrats That Should Leave You Swimming In Cash.

12 Dividend Aristocrats That Should Leave You Swimming In Cash

Johnson & Johnson

3 Best Dividend Kings For The Rest Of 2023.

3 Best Dividend Kings For The Rest Of 2023

PIMCO Dynamic Income Fund

SL Green Realty

Starwood Property

Dividend Harvesting Portfolio Week 111: $11,100 Allocated, $917.46 In Projected Dividends.

Dividend Harvesting Portfolio Week 111: $11,100 Allocated, $917.46 In Projected Dividends

All three of these stocks are trading at great valuations, providing for a nice entry point

3 of the Best Dividend Kings to Buy for the Rest of 2023

Invest In Altria Before It's Too Late

Cronos Group

Novo Nordisk

One Dangerous Dividend Aristocrat To Ignore And 2 Potentially Set To Soar

Bank of America

Norfolk Southern

Omega Healthcare Investors

Shell PLC

Taiwan Semiconductor Manufacturing

There are plenty of risky dividend-paying stocks with company-specific issues that make them clearly dividend stocks to avoid, but there are also some names in this category where the reason to stay away is not so apparent. One such example is with shares in companies facing possible regulatory scrutiny.

7 Dividend Stocks to Sell Before They Face Regulatory Risks

Macy's

Newell Brands

Don't be fooled by high-yielding dividend stocks. Often, dividends are used to mask problems at a company in the same way that air fresheners are used to cover up putrid smells.

3 Dividend Stocks to Sell Before They Get Downgraded by Analysts

Apple

AbbVie

Bristol-Myers

Deere & Company

JPMorgan Chase & Co

Mastercard

Mercedes-Benz Group AG

Microsoft

Schwab US Dividend Equity ETF

Charles Schwab

Suncor Energy

Toronto-Dominion Bank

TotalEnergies SE

U.S. Bancorp

Visa

Verizon

In this article, I will show you how you could allocate $10,000 among my top 20 dividend growth and high dividend yield companies for the month of April. Due to the allocation I have chosen, that I'll discuss in this article, you would achieve a Weighted Average Dividend Yield [FWD] of 3.12% with this portfolio.

How To Allocate $10,000 Among My Top 20 Dividend Stocks Of April 2023

Terms of the settlement won't be public for another month.

Minnesota Settles With Juul As $100 Million Lawsuit Was Set To Wrap Up

Universal Corp

Dividend Kings are the best of the best when it comes to dividend growth stocks, with 50+ year dividend growth streaks. Thanks to rapidly rising interest rates and geopolitical and macroeconomic turmoil, you can buy several dividend kings at compellingly high yields today.

Buy Alert: Which Of The 4 Highest Yielding Dividend Kings?

Tesla

Vertex Pharmaceuticals

Buffett recently gave an intriguing hypothetical scenario that underscores Apple's customer loyalty. Other stocks could pass the threshold mentioned by Buffett -- some quite easily.

Which Stocks Pass Warren Buffett's $10,000 Test?

General Electric

Gateway Investment trimmed its Apple holdings, slashed its GE stake, and bought more Altria stock in the first quarter.

A Low-Volatility Investor Sells Apple and GE Stock, Buys Altria

Equitrans Midstream

Kellogg

Realty Income Corp

Vale S.A.

Buying dividend stocks trading at discount pricing is generally a smart idea. Such equities give owners the dual benefit of price appreciation potential in their forward-looking target prices.

7 Dividend Stocks to Buy That Are Trading at a Discount

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Adult--Americans Overwhelmingly Support Providing Adult Smokers Less Harmful Alternatives to Cigarettes

Americans Overwhelmingly Support Providing Adult Smokers Less Harmful Alternatives to Cigarettes

Altria Group has struggled to grow sales in recent years due to a decline in smoking rates, but its bottom line results have been strong. Investors have shares priced cheaply because of concerns about the company's future.

Altria Group: Cheap And Transformative

Ford Motor Company

AT&T

The search for yield has become even more pressing for income investors, and as inflation outpaces many of the payouts on offer, the list of dividend stocks to sell is getting larger. Of course, dividends aren't the only way investors can make money—share price growth is another factor to consider as well.

3 Dividend Stocks to Sell Before They Get Crushed by Inflation

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA TO HOST WEBCAST OF 2023 FIRST-QUARTER RESULTS

Altria to Host Webcast of 2023 First-Quarter Results

Vape stick maker Juul Labs has agreed to pay a US$462mln settlement to seven US states for its role in creating an underage e-cigarette "epidemic". Under a deal struck with attorney generals in the states, the e-cigarette manufacturer will be required to ensure its products are secured behind retail store counters with cigarettes and that the age of online customers is verified.

Juul agrees to pay US$462mln to settle underage e-cig claims

NEW YORK — Electronic cigarette-maker Juul Labs Inc. will pay $462 million to six states and the District of Columbia, marking the largest settlement the company has reached so far for its role in the youth vaping surge, the attorneys general in several states announced Wednesday.

E-cigarette maker Juul agrees to pay $462 million settlement to 6 states

Juul has now entered settlement agreements totaling more than $2 billion over allegations it targeted minors in advertising for addictive nicotine products.

Juul Takes Another Hit: Will Pay $462 Million To Settle Lawsuits Claiming It Advertised To Kids

Juul Labs, the e-cigarette maker, is paying $462 million to six US states and DC in the largest multi-state settlement yet for the troubled company that has been accused of contributing to the rise of vaping among youth.

Juul to pay $462 million to six states in its largest settlement ever

In addition to the state settlements, the company last year agreed to pay $1.7 billion to settle thousands of lawsuits by local government entities and individual consumers.

E-cig maker Juul to pay $462M to 6 states over youth addiction claims

News for Altria Stock (MO)